SECTOR ADVISORY • PHARMACEUTICALS & MEDICAL HUBS

Healthcare & Life Sciences Infrastructure

Building localized pharmaceutical manufacturing plants, specialized diagnostic centers, and cold-chain distribution networks securing regional health resilience.

Clinical Resilience & Cold Chain Networks

Strategic Positioning in Healthcare

Strengthening African pharmaceutical self-reliance through localized manufacturing of essential medicines, modern cold-chain pharmaceutical distribution, and tertiary specialized diagnostic facilities.

Our Clinical Mandate
We guarantee uninterrupted access to life-saving therapeutics, compliant with WHO Good Manufacturing Practice (GMP) and regional regulatory harmonization standards.
WHO GMP Certified Facilities
100% Cold-Chain Adherence
<24 Hrs Emergency Dispatch
Strategic Positioning in Healthcare
Biomedical Infrastructure
Specialized Therapeutics & Diagnostic Hubs
Core Capabilities & Medical Solutions
Clinical Quality Benchmark
WHO GMP certified manufacturing and ISO 15189 diagnostic laboratory accreditation
Clinical Infrastructure & Logistics

Core Capabilities & Medical Solutions

Constructing specialized tertiary hospitals, pharmaceutical production lines, and emergency supply networks.

01

Localized Pharmaceutical Formulation

High-volume production of essential oral medications, IV fluids, and vaccines compliant with WHO standards.

02

Specialized Tertiary Diagnostic Centers

Turnkey deployment of advanced MRI, CT, and molecular oncology diagnostic centers across regional cities.

03

Temperature-Controlled Medical Cold Chain

Automated temperature-logged logistics fleets ensuring vaccine and biological integrity across remote regions.

04

Hospital EPC & Biomedical Asset Management

Architectural engineering, equipment procurement, and ongoing biomedical maintenance for healthcare systems.

FLAGSHIP DEPLOYMENT • PHARMACEUTICAL RESILIENCE

Localized WHO-GMP Injectable Formulation Facility

Delivered East Africa's first high-throughput automated BFS (Blow-Fill-Seal) intravenous fluid and sterile injectable plant, establishing regional therapeutic independence during global supply crunches.

National Healthcare Impact Procurement Costs Slashed by 35% for Public Hospitals
Localized WHO-GMP Injectable Formulation Facility
60M Units/Yr Audited Outcome
Good Manufacturing Practice & Healthcare Regulations
WHO-GMP Certified Baseline
Full adherence to World Health Organization Good Manufacturing Practice and ISO 15189
Clinical Bioethics & Pharmacovigilance

Good Manufacturing Practice & Healthcare Regulations

Operating sterile production and diagnostic centers under rigorous clinical protocols, WHO standards, and bioethical oversight.

Pharmacy & Poisons Board Licensing

All formulations and clinical distribution channels authorized under strict national pharmaceutical registrations.

Pharmacovigilance & Batch Traceability

Serialized 2D matrix barcode tracking on every medication unit guaranteeing authenticity and preventing counterfeit entry.

Biomedical Waste Treatment Protocols

Automated high-temperature incineration and chemical neutralization treating medical waste prior to disposal.

Healthcare Practice Ingress

Request Biomedical & Pharmaceutical Scoping

Engage our clinical practice desk regarding pharmaceutical manufacturing partnerships, diagnostic center development, or cold-chain logistics.

Makeway Group Mirage Towers Executive Advisory Desk
Life Sciences Desk
Physical Headquarters 12th Floor, Mirage Towers, Waiyaki Way, Westlands, Nairobi, Kenya
Direct Desk Hotline +254 799 000 595
Secure Ingress Email info@makewaygroup.co.ke
Within 24 Business Hours Strict Mutual NCNDA